Abstract
Mitral valve repair is by far the most common operation for degenerative mitral regurgitation. If the procedure is performed before left ventricular dysfunction occurs and atrial fibrillation develops, the operative risk is very low and life expectancy is super imposable to that of the sex- and age-matched population. Despite these achievements, there are areas that could still be improved. Progress in treating degenerative mitral regurgitation is expected to move along several directions. More precise diagnostic methods will be developed to reliably quantify mitral regurgitation and identify early irreversible ventricular and atrial changes. The refinement of surgical techniques and search for new, innovative solutions should never be abandoned. Finally, transcatheter correction of mitral regurgitation represents a new, emerging field of cardiovascular medicine and is expected to have a significant impact on the surgical practice in the future.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
